0.6(top 50%)
impact factor
764(top 20%)
papers
4.1K(top 20%)
citations
24(top 20%)
h-index
0.7(top 50%)
impact factor
873
all documents
4.2K
doc citations
40(top 20%)
g-index
Top Articles
| # | Title | Journal | Year | Citations |
|---|---|---|---|---|
| 1 | Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health | Current Opinion in Endocrinology, Diabetes and Obesity | 2002 | 375 |
| 2 | The role of oxidative stress in diabetic complications | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 135 |
| 3 | Amylinʼs physiology and its role in diabetes | Current Opinion in Endocrinology, Diabetes and Obesity | 1997 | 82 |
| 4 | Receptors for the melanocortin peptides in the central nervous system | Current Opinion in Endocrinology, Diabetes and Obesity | 1994 | 49 |
| 5 | McCune-Albright syndrome: new insights | Current Opinion in Endocrinology, Diabetes and Obesity | 1999 | 42 |
| 6 | Obesity, free fatty acids, and insulin resistance | Current Opinion in Endocrinology, Diabetes and Obesity | 2001 | 38 |
| 7 | Glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase IV inhibitors: new therapeutic agents for the treatment of type 2 diabetes | Current Opinion in Endocrinology, Diabetes and Obesity | 2005 | 38 |
| 8 | Thyroid hormone and the development of the brain | Current Opinion in Endocrinology, Diabetes and Obesity | 1998 | 35 |
| 9 | Polycystic ovary syndrome in adolescents: is there an epidemic? | Current Opinion in Endocrinology, Diabetes and Obesity | 2002 | 33 |
| 10 | Advanced glycation end products in diabetic complications | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 32 |
| 11 | The role of the endocannabinoid system in the regulation of energy homeostasis | Current Opinion in Endocrinology, Diabetes and Obesity | 2005 | 31 |
| 12 | Micronutrient deficiencies and bariatric surgery | Current Opinion in Endocrinology, Diabetes and Obesity | 2006 | 30 |
| 13 | Hypothalamic mechanism of the onset of puberty | Current Opinion in Endocrinology, Diabetes and Obesity | 1999 | 30 |
| 14 | New assay systems for thyrotropin receptor antibodies | Current Opinion in Endocrinology, Diabetes and Obesity | 1999 | 30 |
| 15 | Insulinlike growth factor binding proteins | Current Opinion in Endocrinology, Diabetes and Obesity | 1997 | 29 |
| 16 | Diagnosis of thyroid nodules by fine-needle aspiration biopsy | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 28 |
| 17 | ICU care for patients with diabetes | Current Opinion in Endocrinology, Diabetes and Obesity | 2004 | 28 |
| 18 | Vitamin D deficiency: new perspectives on an old disease | Current Opinion in Endocrinology, Diabetes and Obesity | 2004 | 28 |
| 19 | The potential role of β3 adrenoceptor agonists In the treatment of obesity and diabetes | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 27 |
| 20 | Is neuropeptide Y a naturally occurring appetite transducer? | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 26 |
| 21 | Congenital hypothyroidism: treatment and outcome | Current Opinion in Endocrinology, Diabetes and Obesity | 2005 | 26 |
| 22 | Glucagon-like peptide-1: physiology and therapeutic potential | Current Opinion in Endocrinology, Diabetes and Obesity | 2005 | 26 |
| 23 | Glucose-induced alterations in β-cell cytoplasmic Ca2+ involving the coupling of intracellular Ca2+ stores and plasma membrane ion channels | Current Opinion in Endocrinology, Diabetes and Obesity | 1997 | 25 |
| 24 | Thiazolidinediones are novel insulin-sensitizing agents | Current Opinion in Endocrinology, Diabetes and Obesity | 1995 | 24 |
| 25 | Prenatal diagnosis, treatment, and outcome in infants with congenital adrenal hyperplasia | Current Opinion in Endocrinology, Diabetes and Obesity | 1997 | 24 |
| 26 | Thyroid hormone metabolism in nonthyroidal illness | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 23 |
| 27 | The hexosamine signaling pathway: a new road to drug discovery | Current Opinion in Endocrinology, Diabetes and Obesity | 2002 | 23 |
| 28 | Aldosteroneʼs effects and mechanism of action | Current Opinion in Endocrinology, Diabetes and Obesity | 1997 | 22 |
| 29 | Free fatty acids as target for therapy | Current Opinion in Endocrinology, Diabetes and Obesity | 2004 | 22 |
| 30 | Evaluation of bone density in children | Current Opinion in Endocrinology, Diabetes and Obesity | 2005 | 22 |
| 31 | Gastrointestinal surgery and gut hormones | Current Opinion in Endocrinology, Diabetes and Obesity | 2005 | 22 |
| 32 | Pleiotropic cellular effects of leptin | Current Opinion in Endocrinology, Diabetes and Obesity | 1999 | 22 |
| 33 | Regulation of puberty | Current Opinion in Endocrinology, Diabetes and Obesity | 2001 | 21 |
| 34 | Hyperinsulinemic hypoglycemia following gastric bypass surgery for obesity | Current Opinion in Endocrinology, Diabetes and Obesity | 2006 | 21 |
| 35 | Pendred syndrome: clinical characteristics and molecular basis | Current Opinion in Endocrinology, Diabetes and Obesity | 1999 | 20 |
| 36 | The role of hypothalamic peptides in the control of energy balance and body weight | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 19 |
| 37 | Cytokines within the neuroendocrine system | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 19 |
| 38 | Advances in understanding the regulation and biologic actions of dehydroepiandrosterone | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 19 |
| 39 | The role of adrenodoxin in adrenal steroidogenesis | Current Opinion in Endocrinology, Diabetes and Obesity | 2000 | 19 |
| 40 | Treatment of the polycystic ovary syndrome with lifestyle intervention | Current Opinion in Endocrinology, Diabetes and Obesity | 2002 | 19 |
| 41 | Hemodynamic changes as early markers of diabetic retinopathy | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 18 |
| 42 | Insulin resistance and the polycystic ovary syndrome: recent advances | Current Opinion in Endocrinology, Diabetes and Obesity | 2000 | 18 |
| 43 | Automated insulin delivery for type 1 diabetes | Current Opinion in Endocrinology, Diabetes and Obesity | 2006 | 18 |
| 44 | The role of corticotropin-releasing hormone in the regulation of energy balance | Current Opinion in Endocrinology, Diabetes and Obesity | 1999 | 18 |
| 45 | Behavioral approaches to the treatment of obesity | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 17 |
| 46 | Regulation of aldosterone secretion | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 17 |
| 47 | The molecular link between obesity and diabetes | Current Opinion in Endocrinology, Diabetes and Obesity | 1996 | 17 |
| 48 | Resistance to thyroid hormone in the absence of mutations in the thyroid hormone receptor genes | Current Opinion in Endocrinology, Diabetes and Obesity | 2000 | 17 |
| 49 | Recent advances in the genetics of maturity-onset diabetes of the young and other forms of autosomal dominant diabetes | Current Opinion in Endocrinology, Diabetes and Obesity | 2000 | 17 |
| 50 | Biologic relevance of mammalian bombesin-like peptides and their receptors in human malignancies | Current Opinion in Endocrinology, Diabetes and Obesity | 2003 | 17 |